Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous
Tobramycin
Tobramycin Sulfate
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
281
Rx · 2026 Q1
4.6K
Units dispensed
-32%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| XGen Pharmaceuticals DJB, Inc. | unknown | 2 | SUPPLYING |
| Xiromed, LLC. | unknown | 2 | SUPPLYING |
| Fosun Pharma USA Inc | unknown | 1 | SUPPLYING |
| NorthStar Rx LLC | unknown | 1 | SUPPLYING |
| Eugia US LLC | unknown | 1 | SUPPLYING |
| Gland Pharma Limited | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 22, 2024RECALLRecall (Class II): Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE…
Failed Stability Specification: Water determination was found not complying with specification. — Recalling firm: Eugia US LLC — Nationwide
Pill